EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 0.4069
March 31, 2026 -0.0997
December 31, 2025 -25.50
September 30, 2025 -2.873
June 30, 2025 -4.045
March 31, 2025 -1.691
December 31, 2024 -1.593
September 30, 2024 -0.382
June 30, 2024 -1.738
March 31, 2024 -2.90
December 31, 2023 -3.922
September 30, 2023 -4.704
June 30, 2023 -4.89
March 31, 2023 -4.694
Date Value
December 31, 2022 -6.504
September 30, 2022 -5.348
June 30, 2022 -3.954
March 31, 2022 -8.198
December 31, 2015 -80.14
September 30, 2015 -402.42
June 30, 2015 -273.37
March 31, 2015 -446.80
December 31, 2014 -627.87
September 30, 2014 -1034.62
June 30, 2014 -1586.05
March 31, 2014 -2117.15
December 31, 2013 -532.36

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Teva Pharmaceutical Industries Ltd. -0.5029
RedHill Biopharma Ltd. --
MediWound Ltd. -0.5737
Sol-Gel Technologies Ltd. -1.126
PolyPid Ltd. -0.3467

EPS Diluted (Quarterly) Related Metrics